114 related articles for article (PubMed ID: 3032636)
1. Estrogen receptors and histopathological evaluation of human breast cancer.
Sarría JA; Spitale L; Tobar C; Foresi AM
Eur J Gynaecol Oncol; 1987; 8(2):81-7. PubMed ID: 3032636
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
3. Histological and biological characteristics of microinvasion in mammary carcinomas < or = 2 cm in diameter.
Takasaki T; Akiba S; Sagara Y; Yoshida H
Pathol Int; 1998 Oct; 48(10):800-5. PubMed ID: 9788264
[TBL] [Abstract][Full Text] [Related]
4. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
5. A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.
Kohail HM; Elias EG; el-Nowiem SA; Bashirelahi N; Didolkar MS; Reed WP
Ann Surg; 1985 May; 201(5):611-7. PubMed ID: 2986565
[TBL] [Abstract][Full Text] [Related]
6. Correlation of hormone receptors with pathological features in human breast cancer.
Millis RR
Cancer; 1980 Dec; 46(12 Suppl):2869-71. PubMed ID: 6256055
[TBL] [Abstract][Full Text] [Related]
7. [An immunohistochemical investigation of estrogen receptor in human breast cancer].
Hori M; Furusato M; Aizawa S; Tanaka H; Uchida K
Gan No Rinsho; 1990 Feb; 36(2):143-7. PubMed ID: 1689780
[TBL] [Abstract][Full Text] [Related]
8. [Histochemical study of estradiol receptors and morphologic parameters in breast cancer].
Berger G; Frappart L; Feroldi J
Bull Assoc Anat (Nancy); 1982 Dec; 66(195):431-9. PubMed ID: 6305447
[TBL] [Abstract][Full Text] [Related]
9. Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer.
Berger U; Wilson P; McClelland RA; Davidson J; Coombes RC
Hum Pathol; 1987 Dec; 18(12):1263-7. PubMed ID: 2824329
[TBL] [Abstract][Full Text] [Related]
10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
11. Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer?
Paredes J; Milanezi F; Reis-Filho JS; Leitão D; Athanazio D; Schmitt F
Pathol Res Pract; 2002; 198(12):795-801. PubMed ID: 12608656
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer with late recurrence. A preliminary report].
Hartveit F; Wiig J
Nord Med; 1971 Jun; 85(24):748-50. PubMed ID: 4326356
[No Abstract] [Full Text] [Related]
13. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
[TBL] [Abstract][Full Text] [Related]
14. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
Järvinen TA; Pelto-Huikko M; Holli K; Isola J
Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650
[TBL] [Abstract][Full Text] [Related]
17. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.
Oka K; Suzuki T; Onodera Y; Miki Y; Takagi K; Nagasaki S; Akahira J; Ishida T; Watanabe M; Hirakawa H; Ohuchi N; Sasano H
Int J Cancer; 2011 Apr; 128(8):1770-82. PubMed ID: 20533549
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma].
Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937
[TBL] [Abstract][Full Text] [Related]
19. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
Takagi K; Miki Y; Nakamura Y; Hirakawa H; Kakugawa Y; Amano G; Watanabe M; Ishida T; Sasano H; Suzuki T
Histol Histopathol; 2015 Oct; 30(10):1223-32. PubMed ID: 25873048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
